• Go to navigation
  • Go to content
ProstateLine

Astrazeneca Worldwide

  • AstraZeneca Websites
Astrazeneca.com

Main navigation

  • Home
  • News
  • Prostate cancer
  • AstraZeneca products
  • Treatment guidelines
  • Expert views
  • Pubmed
  • Patient support
  • Congress calendar
  • Congress reports
  • Glossary
  • Register for extra features
  • Links
  • Sitemap

HomePage

  • Prostate cancer news

    • Mar 9, 2010  : Sarcosine fails as marker for prostate cancer detection

      Patients with and without prostate cancer cannot be differentiated by the levels of sarcosine in their urine following rectal digital examination, researchers report.

    • Mar 8, 2010  : ERG/ETVI and PTEN gene loci identify death risk in prostate cancer patients

      Patients at low and high risk for death from prostate cancer can be identified by the presence or absence of the phosphatase and tensin homolog gene and gene rearrangements in

    • Mar 8, 2010  : Increasing hospital admission rate for complications after TRUS-guided biopsy

      The hospital admission rates for complications following transrectal ultrasound-guided prostate biopsy increased dramatically between 1996 and 2005 in Ontario, Canada, and this is primarily due to an increasing rate of infection-related complications, researchers report.

    • Mar 5, 2010  : High doses required for optimal local control after prostate brachytherapy

      Prostate cancer patients treated with permanent prostate brachytherapy who receive a biologically effective dose of more than 200 Gy achieve significantly better local control than patients who receive lower doses of radiation, researchers report.

    more news
Welcome to ProstateLine.com an international educational resource for healthcare professionals with an interest in prostate cancer, provided by AstraZeneca.

Not signed in

Please log in or register to access the site



  • Register
  • Forgotten password?

Information

This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below. 

  • US Patients
  • US HCPs
  • UK Patients
  • UK HCPs
  • Patients Other

Unsubscribe

Unsubscribe

Contact

Contact Us

PubMed

  • Access PubMed

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010